Summary

The global market for Ureteroscopy was estimated to be worth US$ 944 million in 2024 and is forecast to a readjusted size of US$ 1246 million by 2031 with a CAGR of 4.1% during the forecast period 2025-2031.
This report provides a comprehensive assessment of recent tariff adjustments and international strategic countermeasures on Ureteroscopy cross-border industrial footprints, capital allocation patterns, regional economic interdependencies, and supply chain reconfigurations.

Ureteroscopy is an endoscopic technique and device category used for diagnostic visualization and minimally invasive treatment within the urinary tract, primarily the ureter and renal pelvis, including stone retrieval, laser lithotripsy, biopsy, and stent placement. Devices come in semi-rigid and flexible variants and integrate optical or digital imaging, illumination, working channels for instruments (baskets, laser fibers), and deflection mechanisms. Modern ureteroscopes emphasize high-resolution imaging, precise maneuverability, durability, and offer both reusable and single-use models to suit intraoperative, bedside, outpatient, and remote care settings. Their role in advancing minimally invasive urology, accelerating recovery, and improving operative efficiency makes them central to urology product portfolios and capital investment.In 2024, global Ureteroscopy production reached approximately 62.87 k units, with an average global market price of around US$ 15000 perunit.
Rising incidence of urolithiasis, an aging population, and metabolic disorders are fueling clinical demand for advanced ureteroscopes. Company annual reports and market analyses indicate that single-use ureteroscopes and high-resolution digital imaging systems are key growth drivers because they reduce cross-contamination risk and lower repair/reprocessing burdens. Investments in hospital digitalization, integrated ORs, and ERAS protocols further drive procurement of higher-performance, more maneuverable and efficient devices. Government support for primary care capacity building and telemedicine is unlocking demand in emerging markets, offering vendors strategic opportunities to expand geographic reach and differentiate product lines.

Expansion is coupled with regulatory and cost pressures. Leading manufacturers’ annual reports emphasize the centrality of quality systems, regulatory compliance, and supply-chain resilience; stricter device registration, reprocessing and environmental rules increase maintenance and compliance costs for reusable systems. The market also faces competition from low-cost alternatives and emerging non-invasive monitoring technologies. Purchasing consolidation and stronger buyer negotiation power compress margins, forcing companies to rely on technological differentiation and service capabilities to defend pricing and share.
Clinical demand is becoming more segmented: complex and high-risk cases call for durable, high-end reusable scopes, while routine care and primary settings favor disposable, low-maintenance or modular solutions. Brokerage and industry reports note heightened hospital focus on intraoperative workflow efficiency, visualization and integration with lasers and retrieval tools; outpatient and primary sites prioritize readiness and total cost of ownership. Patient outcomes—recovery experience and complication rates—are increasingly influential in procurement decisions.

Upstream inputs include optical modules (miniature cameras, lenses), fiber optics and illumination systems, flexible polymers and articulation materials, metal/alloy drive components, and polymer housings/seals for disposable devices. High-quality imaging and precision mechanical parts are concentrated among a few specialized micro-electronics and precision-manufacturing suppliers, leading to supply-chain concentration. Annual reports and regulatory filings indicate device availability and durability hinge on materials and manufacturing processes for optics and mechanics; fluctuations in raw-material or electronic component supply and tightening environmental compliance can affect lead times and costs. Consequently, manufacturers pursue supplier localization, multi-sourcing and rigorous supplier qualification to mitigate risks and ensure clinical continuity. The average gross profit margin in this industry is 60-75%.

This report aims to provide a comprehensive presentation of the global market for Ureteroscopy, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Ureteroscopy by region & country, by Type, and by Application.
The Ureteroscopy market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Ureteroscopy.

Market Segmentation
By Company
Olympus
Karl Storz
Stryker
Richard Wolf
HOYA
Boston Scientific
Maxer Endoscopy
Segment by Type
Single-Use Ureteroscope
Reuseable Ureteroscope
Segment by Application
Hospitals
Clinic
Ambulatory Surgical Centers
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia-Pacific
Europe
Germany
France
U.K.
Italy
Netherlands
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size (value, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Ureteroscopy manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Ureteroscopy in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Ureteroscopy in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

ページTOPに戻る

Table of Contents

1 Market Overview
1.1 Ureteroscopy Product Introduction
1.2 Global Ureteroscopy Market Size Forecast
1.2.1 Global Ureteroscopy Sales Value (2020-2031)
1.2.2 Global Ureteroscopy Sales Volume (2020-2031)
1.2.3 Global Ureteroscopy Sales Price (2020-2031)
1.3 Ureteroscopy Market Trends & Drivers
1.3.1 Ureteroscopy Industry Trends
1.3.2 Ureteroscopy Market Drivers & Opportunity
1.3.3 Ureteroscopy Market Challenges
1.3.4 Ureteroscopy Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Ureteroscopy Players Revenue Ranking (2024)
2.2 Global Ureteroscopy Revenue by Company (2020-2025)
2.3 Global Ureteroscopy Players Sales Volume Ranking (2024)
2.4 Global Ureteroscopy Sales Volume by Company Players (2020-2025)
2.5 Global Ureteroscopy Average Price by Company (2020-2025)
2.6 Key Manufacturers Ureteroscopy Manufacturing Base and Headquarters
2.7 Key Manufacturers Ureteroscopy Product Offered
2.8 Key Manufacturers Time to Begin Mass Production of Ureteroscopy
2.9 Ureteroscopy Market Competitive Analysis
2.9.1 Ureteroscopy Market Concentration Rate (2020-2025)
2.9.2 Global 5 and 10 Largest Manufacturers by Ureteroscopy Revenue in 2024
2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Ureteroscopy as of 2024)
2.10 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Single-Use Ureteroscope
3.1.2 Reuseable Ureteroscope
3.2 Global Ureteroscopy Sales Value by Type
3.2.1 Global Ureteroscopy Sales Value by Type (2020 VS 2024 VS 2031)
3.2.2 Global Ureteroscopy Sales Value, by Type (2020-2031)
3.2.3 Global Ureteroscopy Sales Value, by Type (%) (2020-2031)
3.3 Global Ureteroscopy Sales Volume by Type
3.3.1 Global Ureteroscopy Sales Volume by Type (2020 VS 2024 VS 2031)
3.3.2 Global Ureteroscopy Sales Volume, by Type (2020-2031)
3.3.3 Global Ureteroscopy Sales Volume, by Type (%) (2020-2031)
3.4 Global Ureteroscopy Average Price by Type (2020-2031)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Hospitals
4.1.2 Clinic
4.1.3 Ambulatory Surgical Centers
4.2 Global Ureteroscopy Sales Value by Application
4.2.1 Global Ureteroscopy Sales Value by Application (2020 VS 2024 VS 2031)
4.2.2 Global Ureteroscopy Sales Value, by Application (2020-2031)
4.2.3 Global Ureteroscopy Sales Value, by Application (%) (2020-2031)
4.3 Global Ureteroscopy Sales Volume by Application
4.3.1 Global Ureteroscopy Sales Volume by Application (2020 VS 2024 VS 2031)
4.3.2 Global Ureteroscopy Sales Volume, by Application (2020-2031)
4.3.3 Global Ureteroscopy Sales Volume, by Application (%) (2020-2031)
4.4 Global Ureteroscopy Average Price by Application (2020-2031)
5 Segmentation by Region
5.1 Global Ureteroscopy Sales Value by Region
5.1.1 Global Ureteroscopy Sales Value by Region: 2020 VS 2024 VS 2031
5.1.2 Global Ureteroscopy Sales Value by Region (2020-2025)
5.1.3 Global Ureteroscopy Sales Value by Region (2026-2031)
5.1.4 Global Ureteroscopy Sales Value by Region (%), (2020-2031)
5.2 Global Ureteroscopy Sales Volume by Region
5.2.1 Global Ureteroscopy Sales Volume by Region: 2020 VS 2024 VS 2031
5.2.2 Global Ureteroscopy Sales Volume by Region (2020-2025)
5.2.3 Global Ureteroscopy Sales Volume by Region (2026-2031)
5.2.4 Global Ureteroscopy Sales Volume by Region (%), (2020-2031)
5.3 Global Ureteroscopy Average Price by Region (2020-2031)
5.4 North America
5.4.1 North America Ureteroscopy Sales Value, 2020-2031
5.4.2 North America Ureteroscopy Sales Value by Country (%), 2024 VS 2031
5.5 Europe
5.5.1 Europe Ureteroscopy Sales Value, 2020-2031
5.5.2 Europe Ureteroscopy Sales Value by Country (%), 2024 VS 2031
5.6 Asia Pacific
5.6.1 Asia Pacific Ureteroscopy Sales Value, 2020-2031
5.6.2 Asia Pacific Ureteroscopy Sales Value by Region (%), 2024 VS 2031
5.7 South America
5.7.1 South America Ureteroscopy Sales Value, 2020-2031
5.7.2 South America Ureteroscopy Sales Value by Country (%), 2024 VS 2031
5.8 Middle East & Africa
5.8.1 Middle East & Africa Ureteroscopy Sales Value, 2020-2031
5.8.2 Middle East & Africa Ureteroscopy Sales Value by Country (%), 2024 VS 2031
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Ureteroscopy Sales Value Growth Trends, 2020 VS 2024 VS 2031
6.2 Key Countries/Regions Ureteroscopy Sales Value and Sales Volume
6.2.1 Key Countries/Regions Ureteroscopy Sales Value, 2020-2031
6.2.2 Key Countries/Regions Ureteroscopy Sales Volume, 2020-2031
6.3 United States
6.3.1 United States Ureteroscopy Sales Value, 2020-2031
6.3.2 United States Ureteroscopy Sales Value by Type (%), 2024 VS 2031
6.3.3 United States Ureteroscopy Sales Value by Application, 2024 VS 2031
6.4 Europe
6.4.1 Europe Ureteroscopy Sales Value, 2020-2031
6.4.2 Europe Ureteroscopy Sales Value by Type (%), 2024 VS 2031
6.4.3 Europe Ureteroscopy Sales Value by Application, 2024 VS 2031
6.5 China
6.5.1 China Ureteroscopy Sales Value, 2020-2031
6.5.2 China Ureteroscopy Sales Value by Type (%), 2024 VS 2031
6.5.3 China Ureteroscopy Sales Value by Application, 2024 VS 2031
6.6 Japan
6.6.1 Japan Ureteroscopy Sales Value, 2020-2031
6.6.2 Japan Ureteroscopy Sales Value by Type (%), 2024 VS 2031
6.6.3 Japan Ureteroscopy Sales Value by Application, 2024 VS 2031
6.7 South Korea
6.7.1 South Korea Ureteroscopy Sales Value, 2020-2031
6.7.2 South Korea Ureteroscopy Sales Value by Type (%), 2024 VS 2031
6.7.3 South Korea Ureteroscopy Sales Value by Application, 2024 VS 2031
6.8 Southeast Asia
6.8.1 Southeast Asia Ureteroscopy Sales Value, 2020-2031
6.8.2 Southeast Asia Ureteroscopy Sales Value by Type (%), 2024 VS 2031
6.8.3 Southeast Asia Ureteroscopy Sales Value by Application, 2024 VS 2031
6.9 India
6.9.1 India Ureteroscopy Sales Value, 2020-2031
6.9.2 India Ureteroscopy Sales Value by Type (%), 2024 VS 2031
6.9.3 India Ureteroscopy Sales Value by Application, 2024 VS 2031
7 Company Profiles
7.1 Olympus
7.1.1 Olympus Company Information
7.1.2 Olympus Introduction and Business Overview
7.1.3 Olympus Ureteroscopy Sales, Revenue, Price and Gross Margin (2020-2025)
7.1.4 Olympus Ureteroscopy Product Offerings
7.1.5 Olympus Recent Development
7.2 Karl Storz
7.2.1 Karl Storz Company Information
7.2.2 Karl Storz Introduction and Business Overview
7.2.3 Karl Storz Ureteroscopy Sales, Revenue, Price and Gross Margin (2020-2025)
7.2.4 Karl Storz Ureteroscopy Product Offerings
7.2.5 Karl Storz Recent Development
7.3 Stryker
7.3.1 Stryker Company Information
7.3.2 Stryker Introduction and Business Overview
7.3.3 Stryker Ureteroscopy Sales, Revenue, Price and Gross Margin (2020-2025)
7.3.4 Stryker Ureteroscopy Product Offerings
7.3.5 Stryker Recent Development
7.4 Richard Wolf
7.4.1 Richard Wolf Company Information
7.4.2 Richard Wolf Introduction and Business Overview
7.4.3 Richard Wolf Ureteroscopy Sales, Revenue, Price and Gross Margin (2020-2025)
7.4.4 Richard Wolf Ureteroscopy Product Offerings
7.4.5 Richard Wolf Recent Development
7.5 HOYA
7.5.1 HOYA Company Information
7.5.2 HOYA Introduction and Business Overview
7.5.3 HOYA Ureteroscopy Sales, Revenue, Price and Gross Margin (2020-2025)
7.5.4 HOYA Ureteroscopy Product Offerings
7.5.5 HOYA Recent Development
7.6 Boston Scientific
7.6.1 Boston Scientific Company Information
7.6.2 Boston Scientific Introduction and Business Overview
7.6.3 Boston Scientific Ureteroscopy Sales, Revenue, Price and Gross Margin (2020-2025)
7.6.4 Boston Scientific Ureteroscopy Product Offerings
7.6.5 Boston Scientific Recent Development
7.7 Maxer Endoscopy
7.7.1 Maxer Endoscopy Company Information
7.7.2 Maxer Endoscopy Introduction and Business Overview
7.7.3 Maxer Endoscopy Ureteroscopy Sales, Revenue, Price and Gross Margin (2020-2025)
7.7.4 Maxer Endoscopy Ureteroscopy Product Offerings
7.7.5 Maxer Endoscopy Recent Development
8 Industry Chain Analysis
8.1 Ureteroscopy Industrial Chain
8.2 Ureteroscopy Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Ureteroscopy Sales Model
8.5.2 Sales Channel
8.5.3 Ureteroscopy Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.1.1 Research Programs/Design
10.1.1.2 Market Size Estimation
10.1.1.3 Market Breakdown and Data Triangulation
10.1.2 Data Source
10.1.2.1 Secondary Sources
10.1.2.2 Primary Sources
10.2 Author Details
10.3 Disclaimer